Could a simple blood test flag lung risk in preemies?

NCT ID NCT06940856

Recruiting now Knowledge-focused Sponsor: Kanuni Sultan Suleyman Training and Research Hospital Source: ClinicalTrials.gov ↗

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study looks back at medical records of 500 premature babies (born before 32 weeks or under 1500 grams) to see if abnormal blood chloride levels in the first weeks of life are linked to a higher risk of death or chronic lung disease (bronchopulmonary dysplasia). Researchers will compare babies who developed lung problems or died with those who did not. The goal is to understand if chloride imbalance could serve as an early warning sign.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If a link is found, it could lead to better monitoring or treatments to protect premature babies' lungs and survival.
What could go wrong: This is an observational review of past records, so it can only show associations, not cause and effect. Results may be affected by other factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA (BPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchopulmonary dysplasia Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRONCHOPULMONARY DYSPLASIA (BPD) CHLORIDE DISORDER MORTALITY PREDICTION

Contacts and locations

Locations

Kanuni Sultan Suleyman Education and Research Hospital
RECRUITING

Istanbul, Turkey, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.